We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoscience | LSE:NAN | London | Ordinary Share | KYG6390E1070 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.375 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTMZ
RNS Number : 6200A
Toumaz Limited
30 September 2015
30 September 2015
Toumaz Limited
Amendment to terms of Director's share options
Toumaz Limited (AIM: TMZ) announces that on 29(th) September 2015, the Company's Board of Directors has formalised an undertaking made by the previous Board that 1,683,835 fully vested options with an exercise price of 6.94p granted to Prof C Toumazou on 30 September 2005 and due to expire on 30 September 2015 have been extended by 12 months to expire on 30 September 2016
Name of contact Jonathan Apps ----------------------------- --------------------- Telephone number of contact +44 (0) 20 7391 0630 ----------------------------- ---------------------
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital audio devices.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLGDCGDDBGUC
(END) Dow Jones Newswires
September 30, 2015 03:00 ET (07:00 GMT)
1 Year Nanoscience Chart |
1 Month Nanoscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions